National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Breast Cancer Prevention (PDQ®)
Patient Version   Health Professional Version   Last Modified: 06/18/2008



Purpose of This PDQ Summary






Overview






Description of Evidence






Get More Information From NCI






Changes To This Summary (06/18/2008)






Questions or Comments About This Summary






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Changes To This Summary (06/18/2008)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Description of Evidence

Added text to state that the incidence of breast cancer can be lowered with selective estrogen receptor modifiers, but whether there is a consequent decrease in breast cancer mortality is unknown.

Added text to state that the incidence of breast cancer increased dramatically in the United States and in many European countries between the 1980s and 1990s (cited Holford et al. as reference 39 and Waller et al. as reference 40).

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov